article thumbnail

N-terminal pro–B-type natriuretic peptide and pulmonary echography are predictors of acute heart failure needing early mechanical ventilation in acute coronary syndrome

Coronary Artery Disease Journal

Methods We analyzed a cohort of patients admitted for ACS between February 2017 and February 2018. Aim The aim of this study was to determine the best clinical predictors of acute heart failure needing mechanical ventilation (MV) in the first 48 h of evolution of patients admitted because of acute coronary syndrome (ACS).

article thumbnail

Occlusion/reperfusion through 6 ‘normal’ ECGs

Dr. Smith's ECG Blog

Eur Heart J 2017 Driver BE, Shroff GR, Smith SW. But others are not as fortunate, so we should learn from these near misses to better identify signs of occlusion and reperfusion. Arch Cardiovasc Dis 2013 Khan AR et al. Posterior reperfusion T-waves: Wellens’ syndrome of the posterior wall. Emerg Med J 2017;34(2):119–23.

STEMI 40
article thumbnail

Do Stents Make You Feel Better?

Dr. Paddy Barrett

Whether stenting a narrowed coronary artery improves symptoms such as chest pain (angina) or shortness of breath is a very different question. Share Angina The classic definition of angina involves the sensation of tightness in the centre of the chest that is brought on with exertion and is relieved with rest. The result?

Stents 59
article thumbnail

Fate of coronary arteries in Constrictive pericarditis

Dr. S. Venkatesan MD

There has been many reports of patients with angina in CP (Ref 1). 2017) Now Robots are being tried to assist in this delicate surgery (CTS-NET 2023 Total Robotic Pericardiectomy for Constrictive Pericarditis) Reference 1.Mahé Angina caused by calcific constrictive pericarditis. 2017 Jan-Feb;59(4):327-340. Ann Intern Med.

article thumbnail

Safe Deferral of Coronary Computed Tomography Angiography for Patients With a Low Pretest Probability of Coronary Artery Disease in 2019 European Society of Cardiology Guidelines

Journal of the American Heart Association

The overall mortality, cardiac deaths, myocardial infarctions, and hospitalizations for unstable angina were acquired from national registry data for 1 to 10 years of follow‐up (median, 4 years). PTP was calculated according to the 2013 and 2019 ESC guidelines.

article thumbnail

Post-event follow-up costs in patients with atherosclerotic cardiovascular disease in Spain

Frontiers in Cardiovascular Medicine

Patients with a new or recurrent episode of ASCVD (angina, acute myocardial infarction, transient ischemic attack, stroke, or peripheral arterial disease) between 1-Jan-2017 and 31-Dec-2018 were included. The resources use within two years of the diagnosis was estimated in order to estimate the average cost of patient follow-up.

article thumbnail

Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk

DAIC

12,16 In 2017, CANTOS (Canakinumab Anti-inflammatory Thrombosis Outcomes Study) provided proof-of-principle that inflammation inhibition in the absence of lipid lowering can significantly reduce cardiovascular event rates and helped to define the interleukin-1 (IL-1) to IL-6 to CRP pathway as a central target in CV disease.16